Magnetic resonance imaging-assessment of early response to certolizumab pegol in rheumatoid arthritis: A randomized, double-blind, placebo-controlled phase IIIb study applying magnetic resonance imaging at week 0, 1, 2, 4, 8 and 16

Mikkel Østergaard; L. Jacobsson; C. Schaufelberger; M.S. Hansen; J. Bijlsma; A. Dudek; M. Reel-Bakalarska; F. Staelens; R. Haake; B. Sundman-Engberg; Henning Bliddal

Magnetic resonance imaging-assessment of early response to certolizumab pegol in rheumatoid arthritis: A randomized, double-blind, placebo-controlled phase IIIb study applying magnetic resonance imaging at week 0, 1, 2, 4, 8 and 16

Mikkel Østergaard, L. Jacobsson, C. Schaufelberger, M.S. Hansen, J. Bijlsma, A. Dudek, M. Reel-Bakalarska, F. Staelens, R. Haake, B. Sundman-Engberg, Henning Bliddal

Originalsprog	Engelsk
Tidsskrift	Arthritis & Rheumatism
Vol/bind	65
Udgave nummer	Suppl. 10
Sider (fra-til)	S842
Antal sider	1
ISSN	0004-3591
Status	Udgivet - 2013

Citationsformater

Østergaard, M., Jacobsson, L., Schaufelberger, C., Hansen, M. S., Bijlsma, J., Dudek, A., Reel-Bakalarska, M., Staelens, F., Haake, R., Sundman-Engberg, B., & Bliddal, H. (2013). Magnetic resonance imaging-assessment of early response to certolizumab pegol in rheumatoid arthritis: A randomized, double-blind, placebo-controlled phase IIIb study applying magnetic resonance imaging at week 0, 1, 2, 4, 8 and 16. Arthritis & Rheumatism, 65(Suppl. 10), S842.

Magnetic resonance imaging-assessment of early response to certolizumab pegol in rheumatoid arthritis: A randomized, double-blind, placebo-controlled phase IIIb study applying magnetic resonance imaging at week 0, 1, 2, 4, 8 and 16. / Østergaard, Mikkel; Jacobsson, L.; Schaufelberger, C. et al.
I: Arthritis & Rheumatism, Bind 65, Nr. Suppl. 10, 2013, s. S842.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Østergaard, M, Jacobsson, L, Schaufelberger, C, Hansen, MS, Bijlsma, J, Dudek, A, Reel-Bakalarska, M, Staelens, F, Haake, R, Sundman-Engberg, B & Bliddal, H 2013, 'Magnetic resonance imaging-assessment of early response to certolizumab pegol in rheumatoid arthritis: A randomized, double-blind, placebo-controlled phase IIIb study applying magnetic resonance imaging at week 0, 1, 2, 4, 8 and 16', Arthritis & Rheumatism, bind 65, nr. Suppl. 10, s. S842.

@article{5524843689b0494ab75ed174431504b6,

title = "Magnetic resonance imaging-assessment of early response to certolizumab pegol in rheumatoid arthritis: A randomized, double-blind, placebo-controlled phase IIIb study applying magnetic resonance imaging at week 0, 1, 2, 4, 8 and 16",

author = "Mikkel {\O}stergaard and L. Jacobsson and C. Schaufelberger and M.S. Hansen and J. Bijlsma and A. Dudek and M. Reel-Bakalarska and F. Staelens and R. Haake and B. Sundman-Engberg and Henning Bliddal",

year = "2013",

language = "English",

volume = "65",

pages = "S842",

journal = "Arthritis & Rheumatism",

issn = "0004-3591",

publisher = "John/Wiley & Sons, Inc. John/Wiley & Sons Ltd",

number = "Suppl. 10",

}

TY - ABST

T1 - Magnetic resonance imaging-assessment of early response to certolizumab pegol in rheumatoid arthritis: A randomized, double-blind, placebo-controlled phase IIIb study applying magnetic resonance imaging at week 0, 1, 2, 4, 8 and 16

AU - Østergaard, Mikkel

AU - Jacobsson, L.

AU - Schaufelberger, C.

AU - Hansen, M.S.

AU - Bijlsma, J.

AU - Dudek, A.

AU - Reel-Bakalarska, M.

AU - Staelens, F.

AU - Haake, R.

AU - Sundman-Engberg, B.

AU - Bliddal, Henning

PY - 2013

Y1 - 2013

M3 - Conference abstract in journal

SN - 0004-3591

VL - 65

SP - S842

JO - Arthritis & Rheumatism

JF - Arthritis & Rheumatism

IS - Suppl. 10

ER -